Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 707
Selected: 0
NCT IDTitle
NCT03259555A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
NCT02722863Samsca Post Marketing Surveillance Study
NCT03198078Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
NCT04081363Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)
NCT02404532Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)
NCT05402111A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
NCT05326347A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
NCT00615589Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen
NCT01795547Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
NCT00876343Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT01395017Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
NCT05066724Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment
NCT03423680A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
NCT07075328A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
NCT02012959Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
NCT02483169PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
NCT01670279Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
NCT00462670A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT01651156Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
NCT02006641Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
NCT01397786Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
NCT00606177A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT02212613Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT01048788A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg
NCT05221502Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
NCT00791921Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
NCT02219009Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT01696617Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
NCT01634243A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
NCT00216749Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT02349919Effect of Oral Procaterol on Postinfectious Persistent Cough
NCT06931080Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
NCT02091882Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT02360319Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
NCT07225712A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
NCT06628128A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT02477670Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
NCT00002337A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease
NCT03487770Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT07166783Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
NCT03585127Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia
NCT01481142Adacolumn in Refractory UC Patients Trial
NCT05848700A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
NCT02538016TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
NCT00905307Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
NCT01439009Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients
NCT02293993Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT01711034A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer